Our work identifies novel potential candidate biomarkers of RA diagnosis and therapeutic targets including CTSL-1, SORT1, SAA-4, TNFRSF10A, ST6GAL1 and CCL18, in two different cohort of RA patients. Here, TNFRSF10A is linked to rheumatoid arthritis.